Production (Stage)
BioAge Labs, Inc.
BIOA
$3.98
$0.030.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.45M | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.45M | -- | -- | -- | -- |
| Cost of Revenue | 11.11M | 9.32M | 9.32M | 9.32M | 9.32M |
| Gross Profit | -9.66M | -9.32M | -9.32M | -9.32M | -9.32M |
| SG&A Expenses | 22.45M | 19.16M | 16.54M | 15.16M | 14.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.28M | 78.19M | 66.43M | 51.57M | 49.71M |
| Operating Income | -81.83M | -78.19M | -66.43M | -51.57M | -49.71M |
| Income Before Tax | -71.05M | -71.11M | -70.94M | -62.16M | -65.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.05 | -71.11 | -70.94 | -62.16 | -65.76 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.05M | -71.11M | -70.94M | -62.16M | -65.76M |
| EBIT | -81.83M | -78.19M | -66.43M | -51.57M | -49.71M |
| EBITDA | -81.66M | -78.03M | -66.27M | -51.39M | -49.55M |
| EPS Basic | -15.58 | -22.99 | -34.93 | -36.97 | -39.31 |
| Normalized Basic EPS | -9.74 | -14.27 | -17.97 | -19.24 | -20.70 |
| EPS Diluted | -15.58 | -22.99 | -34.93 | -36.97 | -39.31 |
| Normalized Diluted EPS | -9.74 | -14.27 | -17.97 | -19.24 | -20.70 |
| Average Basic Shares Outstanding | 77.07M | 42.89M | 8.55M | 6.73M | 6.69M |
| Average Diluted Shares Outstanding | 77.07M | 42.89M | 8.55M | 6.73M | 6.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |